Patients with critical COVID-19 and respiratory failure treated with RLF-100™ (aviptadil) have a 9-fold increased probability of survival and recovery from respiratory failure than those patients only on the standard of care, reports Relief Therapeutics Holding AG...
Severe COVID-19
Category
Flemish Institute for Biotechnology Testing Leukine on COVID-19 Patients Lungs in Hopes to Prevent Dangerous ICU Cases
Investigators at the university hospital of Ghent and the Flemish Institute for Biotechnology (VIB) have commenced a clinical trial assessing the drug Leukine to identify if it could be useful in the treatment of COVID-19 patients. The Belgium-based investigators hope...
Genentech (Roche) Collaborates with BARDA to Launch Actemra Clinical Trial for Adult Patients with Severe COVID-19 Pneumonia
Genentech (Roche) plans a Phase III clinical trial to assess its marketed drug Actemra (tocilizumab) as a treatment for severe cases of COVID-19 in adults. In collaboration with the Biomedical Advanced Research and Development Authority (BARDA), the prominent company...
Sobi’s Anakinra & Emapalumab Requested for Use in Targeted Clinical Study in Italy to Address Severe COVID-19 Cases
A publicly traded Swedish biotech will soon launch a short-term clinical trial evaluating the efficacy and safety of anakinra and emapalumab to treat hyper-inflammatory syndrome—one of the most dangerous complications associated with severe COVID-19. Swedish Orphan...